<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16">In recent years, recurrent measles outbreaks, primarily affecting children below 5 years of age [
 <xref ref-type="bibr" rid="CR1">1</xref>], have been reported in several areas of Ethiopia [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR14">14</xref>], including the Oromia Region [
 <xref ref-type="bibr" rid="CR4">4</xref>]. In Ethiopia, the national Expanded Programme on Immunization was established in 1980 and consists of the first dose of measles-containing vaccine (MCV1) administered at 9 months of age. Routine immunization of infants is supplemented by planned campaigns at 2- and 5-year intervals [
 <xref ref-type="bibr" rid="CR3">3</xref>], aimed at increasing vaccination coverage and providing the opportunity for a second dose of vaccine to children who did not respond to the first one [
 <xref ref-type="bibr" rid="CR3">3</xref>].
</p>
